Please introduce your firm, your role, and what you cover in terms of the psychedelics market. Mr. Trucchio: I work at H.C. Wainwright, an investment bank headquartered in New York, as a senior health ...

So, it’s been a few years since you last spoke with The Wall Street Transcript. Let’s start with a refresher about the company and its history and how it’s evolved over the years. Mr. Groesbeck: I’ll ...

Let’s start with a brief overview of the company, including some major milestones. Mr. Beasley: Cansortium is a publicly traded company, which is a Canadian registered entity on the Ontario Exchange.

Let’s start with a brief history of the company and its focus on accessories for cannabis. Ms. Sher: Sure. So Greenlane is the leading global omnichannel platform for the development and distribution ...

CEO Silviu Itescu explains how Mesoblast changes a disease that is fatal 70% or 90% to a disease that can be cured.

Interview with Nicolas Poirier, CEO at OSE Immunotherapeutics a biotech with a compound that is a therapeutic cancer vaccine, ...

Could you tell us about the firm and your role there? Mr. Khuller: I’m the Vice President and Portfolio Manager at Letko Brosseau in Montreal, Canada. We manage about CAD18 billion in assets for our ...

Could you tell me about Premier? Mr. Alkire: Sure. Premier is a health care improvement company. We have two different segments to our business. We have a supply chain segment and a performance ...

Ofer Gonen is CEO of MediWound Ltd. Prior to his CEO appointment in 2022, Mr. Gonen served as CEO of Clal Biotechnology Industries Ltd. (TASE:CBI), Israel’s leading life science investment ...

So let’s start with a brief history of the company and its mission. Mr. Pilcher: Sure. So Neuren is an interesting company, which has had a long history and a couple of incarnations. Twenty years ago ...